On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was -1.53% drop from the session before settling in for the closing price of $0.19. A 52-week range for TNXP has been $0.12 – $22.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 31.99%. With a float of $186.89 million, this company’s outstanding shares have now reached $186.89 million.
In an organization with 103 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 7.54%, operating margin of -731.49%, and the pretax margin is -1197.86%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tonix Pharmaceuticals Holding Corp stocks. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.00%, while institutional ownership is 1.51%.
Tonix Pharmaceuticals Holding Corp (TNXP) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 17.6 earnings per share (EPS) during the time that was better than consensus figure (set at -44) by 61.6. Wall Street market experts anticipate that the next fiscal year will bring earnings of -6.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.99% per share during the next fiscal year.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
You can see what Tonix Pharmaceuticals Holding Corp (TNXP) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.56, a number that is poised to hit -3.95 in the next quarter and is forecasted to reach -14.23 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Let’s dig in a bit further. During the last 5-days, its volume was 30.51 million. That was better than the volume of 14.14 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 41.02%. Additionally, its Average True Range was 0.02.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 9.46%, which indicates a significant decrease from 40.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 116.47% in the past 14 days, which was higher than the 113.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1553, while its 200-day Moving Average is $3.1956. However, in the short run, Tonix Pharmaceuticals Holding Corp’s stock first resistance to watch stands at $0.2011. Second resistance stands at $0.2155. The third major resistance level sits at $0.2260. If the price goes on to break the first support level at $0.1762, it is likely to go to the next support level at $0.1657. The third support level lies at $0.1513 if the price breaches the second support level.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are 186,894K outstanding shares of the company, which has a market capitalization of 35.17 million. As of now, sales total 7,770 K while income totals -116,660 K. Its latest quarter income was 2,820 K while its last quarter net income were -14,210 K.
